137 related articles for article (PubMed ID: 23615535)
1. Prion protein: structural features and related toxicity.
Hu PP; Huang CZ
Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):435-41. PubMed ID: 23615535
[TBL] [Abstract][Full Text] [Related]
2. Prion protein oligomer and its neurotoxicity.
Huang P; Lian F; Wen Y; Guo C; Lin D
Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):442-51. PubMed ID: 23557632
[TBL] [Abstract][Full Text] [Related]
3. Experimental approaches to the interaction of the prion protein with nucleic acids and glycosaminoglycans: Modulators of the pathogenic conversion.
Silva JL; Vieira TC; Gomes MP; Rangel LP; Scapin SM; Cordeiro Y
Methods; 2011 Mar; 53(3):306-17. PubMed ID: 21145399
[TBL] [Abstract][Full Text] [Related]
4. The structure of prion: is it enough for interpreting the diverse phenotypes of prion diseases?
Tian C; Dong X
Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):429-34. PubMed ID: 23459557
[TBL] [Abstract][Full Text] [Related]
5. Conformational conversion of prion protein in prion diseases.
Zhou Z; Xiao G
Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):465-76. PubMed ID: 23580591
[TBL] [Abstract][Full Text] [Related]
6. Prion encephalopathies of animals and humans.
Prusiner SB
Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
[TBL] [Abstract][Full Text] [Related]
7. Synthetic prions and other human neurodegenerative proteinopathies.
Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
[TBL] [Abstract][Full Text] [Related]
8. Intriguing nucleic-acid-binding features of mammalian prion protein.
Silva JL; Lima LM; Foguel D; Cordeiro Y
Trends Biochem Sci; 2008 Mar; 33(3):132-40. PubMed ID: 18243708
[TBL] [Abstract][Full Text] [Related]
9. Species-barrier phenomenon in prion transmissibility from a viewpoint of protein science.
Hagiwara K; Hara H; Hanada K
J Biochem; 2013 Feb; 153(2):139-45. PubMed ID: 23284000
[TBL] [Abstract][Full Text] [Related]
10. Structural insights into alternate aggregated prion protein forms.
Polano M; Bek A; Benetti F; Lazzarino M; Legname G
J Mol Biol; 2009 Nov; 393(5):1033-42. PubMed ID: 19720066
[TBL] [Abstract][Full Text] [Related]
11. Generation of genuine prion infectivity by serial PMCA.
Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
[TBL] [Abstract][Full Text] [Related]
12. Insights into prion strains and neurotoxicity.
Aguzzi A; Heikenwalder M; Polymenidou M
Nat Rev Mol Cell Biol; 2007 Jul; 8(7):552-61. PubMed ID: 17585315
[TBL] [Abstract][Full Text] [Related]
13. The highways and byways of prion protein trafficking.
Campana V; Sarnataro D; Zurzolo C
Trends Cell Biol; 2005 Feb; 15(2):102-11. PubMed ID: 15695097
[TBL] [Abstract][Full Text] [Related]
14. Molecular dynamics studies on 3D structures of the hydrophobic region PrP(109-136).
Zhang J; Zhang Y
Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):509-19. PubMed ID: 23563221
[TBL] [Abstract][Full Text] [Related]
15. The emerging principles of mammalian prion propagation and transmissibility barriers: Insight from studies in vitro.
Surewicz WK; Jones EM; Apetri AC
Acc Chem Res; 2006 Sep; 39(9):654-62. PubMed ID: 16981682
[TBL] [Abstract][Full Text] [Related]
16. Monitoring prion protein stability by NMR.
Julien O; Graether SP; Sykes BD
J Toxicol Environ Health A; 2009; 72(17-18):1069-74. PubMed ID: 19697241
[TBL] [Abstract][Full Text] [Related]
17. PrP N-terminal domain triggers PrP(Sc)-like aggregation of Dpl.
Erlich P; Cesbron JY; Lemaire-Vieille C; Curt A; Andrieu JP; Schoehn G; Jamin M; Gagnon J
Biochem Biophys Res Commun; 2008 Jan; 365(3):478-83. PubMed ID: 17997980
[TBL] [Abstract][Full Text] [Related]
18. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc).
Bocharova OV; Breydo L; Parfenov AS; Salnikov VV; Baskakov IV
J Mol Biol; 2005 Feb; 346(2):645-59. PubMed ID: 15670611
[TBL] [Abstract][Full Text] [Related]
19. Interactions of recombinant prions with compounds of therapeutical significance.
Georgieva D; Schwark D; von Bergen M; Redecke L; Genov N; Betzel C
Biochem Biophys Res Commun; 2006 Jun; 344(2):463-70. PubMed ID: 16630566
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning and sequence analysis of prion protein gene in Xiji donkey in China.
Zhang Z; Wang R; Xu L; Yuan F; Zhou X; Yang L; Yin X; Xu B; Zhao D
Gene; 2013 Oct; 529(2):345-50. PubMed ID: 23954254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
